Literature DB >> 1104190

The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family members.

L E Spitler, A S Levin, D P Stites, H H Fudenberg, H Huber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1104190     DOI: 10.1016/0008-8749(75)90204-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

1.  Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells.

Authors:  H Y She; S Rockow; J Tang; R Nishimura; E Y Skolnik; M Chen; B Margolis; W Li
Journal:  Mol Biol Cell       Date:  1997-09       Impact factor: 4.138

2.  Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS).

Authors:  H U Simon; E A Higgins; M Demetriou; A Datti; K A Siminovitch; J W Dennis
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

3.  Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome.

Authors:  H U Simon; G B Mills; S Hashimoto; K A Siminovitch
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Immunologic studies before and after splenectomy in a patient with the Wiskott-Aldrich syndrome.

Authors:  A P Knutsen; W F Rosse; T R Kinney; R H Buckley
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

5.  Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains.

Authors:  O M Rivero-Lezcano; A Marcilla; J H Sameshima; K C Robbins
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

6.  Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.

Authors:  J Zhang; A Shehabeldin; L A da Cruz; J Butler; A K Somani; M McGavin; I Kozieradzki; A O dos Santos; A Nagy; S Grinstein; J M Penninger; K A Siminovitch
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.